拜玛林制药与Ascendis达成一致,双方将撤销所有未决诉讼,且该撤销为带偏见撤销,不可再次起诉。此消息源自SEC文件披露。
拜玛林制药与Ascendis达成一致,双方将撤销所有未决诉讼,且该撤销为带偏见撤销,不可再次起诉。此消息源自SEC文件披露。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.